“…Interestingly, psoriasis, a Th1-Th17-mediated disease [1], was found in 4% of our patients (10/253), a percentage which is similar to the psoriasis prevalence in general population, suggesting a possible overlap between Th1-Th17 and Th-2 pathways in AD, especially in adult-onset or persistent chronic forms as reported by a study conducted among Korean adults visiting health service centre in Seul [13]. Indeed, the importance of Th1-Th17 pathway in AD course is further supported by a very recent study which showed that the profile of Cutaneous Mesenchymal Stem Cells, obtained from patients suffering from chronic AD, retraces a Th1-Th17 environment [up-regulation of interleukin (IL)6, IL8, IL12, IL13, IL17A, IL17F, transforming growth factor-b, interferon-c, whereas Th2 chemokines such as IL2, IL4, IL5, and IL23A were down-regulated) [21].…”